← Back to Search

Bicycle Safety Education for Adolescent Bicycling Safety

N/A
Recruiting
Led By Cara Hamann, PHD
Research Sponsored by Cara J. Hamann
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
9 to 12 years old
Fluency in English for the adolescent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within a six month period
Awards & highlights

Study Summary

This trial will evaluate a community-based bicycle safety education program with and without an in-person parent training component to see if it changes behavior.

Who is the study for?
This trial is for English-speaking adolescents aged 9 to 12 who have their own bicycle and ride at least twice a week. They must not have been in similar bike safety programs before, live in Johnson County, Iowa, and be willing to join after school or summer bicycling safety sessions. Only one child per family can participate, excluding wards of the state or those with conditions that make cycling unsafe.Check my eligibility
What is being tested?
The study tests a community-based bicycle safety education program (Bike Club) against an enhanced version with parent training (Bike Club Plus), compared to no intervention. Adolescents' bikes will be fitted with GPS/video tech (Pedal Portal) to track behavior and risk exposure while biking.See study design
What are the potential side effects?
There are no medical side effects as this is an educational intervention; however, participants may experience increased awareness of bicycling risks which could affect their confidence or stress levels temporarily.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 9 and 12 years old.
Select...
I am a teenager who speaks and understands English well.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two weeks of data collection within a six-month period
This trial's timeline: 3 weeks for screening, Varies for treatment, and two weeks of data collection within a six-month period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of positive and negative behaviors relative to the overall number of instances of a given event behavior
Rate of safety behaviors per 100 miles/minutes ridden
Rate of safety-relevant events per 100 miles/minutes ridden
Secondary outcome measures
Difference in identification and recall of Cues to Action
Difference in knowledge tests scores
Difference in mean ratings of perceptions
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Bike Club PlusExperimental Treatment1 Intervention
Participants will receive an enhanced version of the 12-hour bicycle safety education program which will include a parent training session on bicycling safety best practices, child development as it relates to bicycling, strategies for practice at home, and feedback on their adolescent's bicycling performance.
Group II: Bike ClubExperimental Treatment1 Intervention
Participants will receive a 12-hour bicycle safety education program
Group III: Control GroupActive Control1 Intervention
The control group will not receive any bicycle safety education programming.

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,978 Previous Clinical Trials
2,680,173 Total Patients Enrolled
1 Trials studying Knowledge
856 Patients Enrolled for Knowledge
Cara J. HamannLead Sponsor
Cara Hamann, PHDPrincipal InvestigatorUniversity of Iowa College of Public Health; University of Iowa Injury Prevention Research Center

Media Library

Bike Club Clinical Trial Eligibility Overview. Trial Name: NCT05265689 — N/A
Knowledge Research Study Groups: Bike Club, Bike Club Plus, Control Group
Knowledge Clinical Trial 2023: Bike Club Highlights & Side Effects. Trial Name: NCT05265689 — N/A
Bike Club 2023 Treatment Timeline for Medical Study. Trial Name: NCT05265689 — N/A
~25 spots leftby Oct 2024